Finally, we found that the expression of FZD10, either alone or in combination with FASN, predicted worse outcomes for NPC patients, and patients with a deficiency of both FZD10 and FASN expressions had the best overall survival. Here, FZD10 is linked to nasopharyngeal carcinoma.